Reid M Ness, Xavier Llor, Mohammad Ali Abbass, Shrinivas Bishu, Christopher T Chen, Gregory Cooper, Dayna S Early, Mark Friedman, David Fudman, Francis M Giardiello, Kathryn Glaser, Surya Gurudu, Michael Hall, Lyen C Huang, Rachel Issaka, Bryson Katona, Trilokesh Kidambi, Audrey J Lazenby, Jennifer Maratt, Arnold J Markowitz, Joseph Marsano, Folasade P May, Robert J Mayer, Kinga Olortegui, Swati Patel, Shajan Peter, Laura D Porter, Mehnaz Shafi, Peter P Stanich, Jonathan Terdiman, Peter Vu, Jennifer M Weiss, Elizabeth Wood, Carly J Cassara, Vaishnavi Sambandam
{"title":"NCCN Guidelines® Insights：结直肠癌筛查，1.2024 版。","authors":"Reid M Ness, Xavier Llor, Mohammad Ali Abbass, Shrinivas Bishu, Christopher T Chen, Gregory Cooper, Dayna S Early, Mark Friedman, David Fudman, Francis M Giardiello, Kathryn Glaser, Surya Gurudu, Michael Hall, Lyen C Huang, Rachel Issaka, Bryson Katona, Trilokesh Kidambi, Audrey J Lazenby, Jennifer Maratt, Arnold J Markowitz, Joseph Marsano, Folasade P May, Robert J Mayer, Kinga Olortegui, Swati Patel, Shajan Peter, Laura D Porter, Mehnaz Shafi, Peter P Stanich, Jonathan Terdiman, Peter Vu, Jennifer M Weiss, Elizabeth Wood, Carly J Cassara, Vaishnavi Sambandam","doi":"10.6004/jnccn.2024.0047","DOIUrl":null,"url":null,"abstract":"<p><p>The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.</p>","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"22 7","pages":"438-446"},"PeriodicalIF":14.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.\",\"authors\":\"Reid M Ness, Xavier Llor, Mohammad Ali Abbass, Shrinivas Bishu, Christopher T Chen, Gregory Cooper, Dayna S Early, Mark Friedman, David Fudman, Francis M Giardiello, Kathryn Glaser, Surya Gurudu, Michael Hall, Lyen C Huang, Rachel Issaka, Bryson Katona, Trilokesh Kidambi, Audrey J Lazenby, Jennifer Maratt, Arnold J Markowitz, Joseph Marsano, Folasade P May, Robert J Mayer, Kinga Olortegui, Swati Patel, Shajan Peter, Laura D Porter, Mehnaz Shafi, Peter P Stanich, Jonathan Terdiman, Peter Vu, Jennifer M Weiss, Elizabeth Wood, Carly J Cassara, Vaishnavi Sambandam\",\"doi\":\"10.6004/jnccn.2024.0047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.</p>\",\"PeriodicalId\":17483,\"journal\":{\"name\":\"Journal of the National Comprehensive Cancer Network\",\"volume\":\"22 7\",\"pages\":\"438-446\"},\"PeriodicalIF\":14.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Comprehensive Cancer Network\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.6004/jnccn.2024.0047\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2024.0047","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.
The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age at which to initiate screening in average-risk individuals and those with increased risk based on personal history of childhood, adolescent, and young adult cancer.
期刊介绍：
JNCCN—Journal of the National Comprehensive Cancer Network is a peer-reviewed medical journal read by over 25,000 oncologists and cancer care professionals nationwide. This indexed publication delivers the latest insights into best clinical practices, oncology health services research, and translational medicine. Notably, JNCCN provides updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), review articles elaborating on guideline recommendations, health services research, and case reports that spotlight molecular insights in patient care.
Guided by its vision, JNCCN seeks to advance the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and scientific studies related to oncology health services research. This encompasses quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship.
JNCCN boasts indexing by prominent databases such as MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus, reinforcing its standing as a reputable source for comprehensive information in the field of oncology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
